These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 29961995)
1. In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics study. Valko PO; Roschitzki B; Faigle W; Grossmann J; Panse C; Biro P; Dambach M; Spahn DR; Weller M; Martin R; Baumann CR J Sleep Res; 2019 Jun; 28(3):e12721. PubMed ID: 29961995 [TBL] [Abstract][Full Text] [Related]
2. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis. Collins MA; An J; Hood BL; Conrads TP; Bowser RP J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960 [TBL] [Abstract][Full Text] [Related]
3. A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases. Menon KN; Steer DL; Short M; Petratos S; Smith I; Bernard CC Mol Cell Proteomics; 2011 Jun; 10(6):M110.000042. PubMed ID: 21421798 [TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers. Ottervald J; Franzén B; Nilsson K; Andersson LI; Khademi M; Eriksson B; Kjellström S; Marko-Varga G; Végvári A; Harris RA; Laurell T; Miliotis T; Matusevicius D; Salter H; Ferm M; Olsson T J Proteomics; 2010 Apr; 73(6):1117-32. PubMed ID: 20093204 [TBL] [Abstract][Full Text] [Related]
10. Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR). Guldbrandsen A; Farag YM; Lereim RR; Berven FS; Barsnes H Methods Mol Biol; 2019; 2044():377-391. PubMed ID: 31432427 [TBL] [Abstract][Full Text] [Related]
11. Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid. Bastos P; Ferreira R; Manadas B; Moreira PI; Vitorino R Crit Rev Clin Lab Sci; 2017 May; 54(3):185-204. PubMed ID: 28393582 [TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomic analysis of cerebrospinal fluid of women newly diagnosed with multiple sclerosis. Jankovska E; Lipcseyova D; Svrdlikova M; Pavelcova M; Kubala Havrdova E; Holada K; Petrak J Int J Neurosci; 2022 Jul; 132(7):724-734. PubMed ID: 33059501 [TBL] [Abstract][Full Text] [Related]
13. Discovery of Novel Biomarkers for Diagnosing and Predicting the Progression of Multiple Sclerosis Using TMT-Based Quantitative Proteomics. Shi Y; Ding Y; Li G; Wang L; Osman RA; Sun J; Qian L; Zheng G; Zhang G Front Immunol; 2021; 12():700031. PubMed ID: 34489947 [TBL] [Abstract][Full Text] [Related]